Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shibo Jiang

Showing results (41-50 of 580) with videos related to

Pageof 58
Sort By:
The Lancet. Infectious Diseases|October 28, 2006
China needs safe and effective microbicides for preventing sexual transmission of HIVShibo Jiang, Shuwen Liu, Alan Stone
Current Pharmaceutical Design|February 3, 2007
HIV entry inhibitors targeting gp41: from polypeptides to small-molecule compoundsShuwen Liu, Shuguang Wu, Shibo Jiang
Cell Chemical Biology|March 30, 2022
Small-molecule HIV-1 entry inhibitors targeting the epitopes of broadly neutralizing antibodiesShibo Jiang, Alexander Tuzikov, Alexander Andrianov
Peptides|January 7, 2004
Determination of the HIV-1 gp41 fusogenic core conformation modeled by synthetic peptides: applicable for identification of HIV-1 fusion inhibitorsShuwen Liu, Qian Zhao, Shibo Jiang
Emerging Microbes & Infections|February 2, 2020
An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategiesShibo Jiang, Lanying Du, Zhengli Shi
The Journal of Infection|May 21, 2013
Antibodies induced by receptor-binding domain in spike protein of SARS-CoV do not cross-neutralize the novel human coronavirus hCoV-EMCLanying Du, Cuiqing Ma, Shibo Jiang
Biomedical Journal|June 29, 2013
The outbreak of avian influenza A (H7N9) in China: current status and future prospectsLu Lu, Biao He, Shibo Jiang
Advances in Experimental Medicine and Biology|April 12, 2022
Virus Entry Inhibitors: Past, Present, and FutureShan Su, Wei Xu, Shibo Jiang
Advances in Experimental Medicine and Biology|April 12, 2022
Peptide-Based HIV Entry InhibitorsJing Pu, Qian Wang, Shibo Jiang
Trends in Immunology|May 5, 2020
Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses: (Trends in Immunology 41, 355-359; 2020)Shibo Jiang, Christopher Hillyer, Lanying Du
Pageof 58

Showing results (41-50 of 580) with videos related to

Sort By:
Pageof 58
The Lancet. Infectious Diseases|October 28, 2006
China needs safe and effective microbicides for preventing sexual transmission of HIVShibo Jiang, Shuwen Liu, Alan Stone
Current Pharmaceutical Design|February 3, 2007
HIV entry inhibitors targeting gp41: from polypeptides to small-molecule compoundsShuwen Liu, Shuguang Wu, Shibo Jiang
Cell Chemical Biology|March 30, 2022
Small-molecule HIV-1 entry inhibitors targeting the epitopes of broadly neutralizing antibodiesShibo Jiang, Alexander Tuzikov, Alexander Andrianov
Peptides|January 7, 2004
Determination of the HIV-1 gp41 fusogenic core conformation modeled by synthetic peptides: applicable for identification of HIV-1 fusion inhibitorsShuwen Liu, Qian Zhao, Shibo Jiang
Emerging Microbes & Infections|February 2, 2020
An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategiesShibo Jiang, Lanying Du, Zhengli Shi
The Journal of Infection|May 21, 2013
Antibodies induced by receptor-binding domain in spike protein of SARS-CoV do not cross-neutralize the novel human coronavirus hCoV-EMCLanying Du, Cuiqing Ma, Shibo Jiang
Biomedical Journal|June 29, 2013
The outbreak of avian influenza A (H7N9) in China: current status and future prospectsLu Lu, Biao He, Shibo Jiang
Advances in Experimental Medicine and Biology|April 12, 2022
Virus Entry Inhibitors: Past, Present, and FutureShan Su, Wei Xu, Shibo Jiang
Advances in Experimental Medicine and Biology|April 12, 2022
Peptide-Based HIV Entry InhibitorsJing Pu, Qian Wang, Shibo Jiang
Trends in Immunology|May 5, 2020
Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses: (Trends in Immunology 41, 355-359; 2020)Shibo Jiang, Christopher Hillyer, Lanying Du
Pageof 58